A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

This study is testing REGEND003, an experimental treatment, in people who have both Type 2 diabetes and chronic kidney disease (CKD). Researchers want to see if it can slow kidney damage in these patients. **You may be eligible if...** - You are 30–75 years old - You have had Type 2 diabetes for at least 1 year - You have been diagnosed with chronic kidney disease - You are willing to follow all study procedures **You may NOT be eligible if...** - You are pregnant, nursing, or planning a pregnancy within a year - You have active HIV, syphilis, hepatitis B (active, not carrier), or hepatitis C (active) - You have a current or recent cancer (within 2 years) - You have Type 1 diabetes - You are on dialysis - You have had severe low blood sugar episodes recently - You cannot tolerate a kidney biopsy or injection procedure - You have a history of kidney transplant or inherited kidney disease - You have a recent severe illness, psychiatric history, or epilepsy Talk to your doctor to see if this trial is right for you.